Dewey M, Siebes M, Kachelrieß M, et al. Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia. Nat Rev Cardiol. 2020;17(7):427–50.

Article  PubMed  PubMed Central  Google Scholar 

Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.

Article  PubMed  Google Scholar 

Hachamovitch R. Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease effectively identifies revascularization candidates. Circ Cardiovasc Imaging. 2015;8(5):discussion.

Article  PubMed  Google Scholar 

Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 2000;101(12):1465–78.

Article  PubMed  Google Scholar 

Lima RS, Watson DD, Goode AR, et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol. 2003;42(1):64–70.

Article  PubMed  Google Scholar 

Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007;14(4):521–8.

Article  PubMed  Google Scholar 

Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13(1):24–33.

Article  PubMed  Google Scholar 

Agostini D, Marie PY, Ben-Haim S, et al. Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging. 2016;43(13):2423–32.

Article  PubMed  Google Scholar 

Nkoulou R, Fuchs TA, Pazhenkottil AP, et al. Absolute myocardial blood Flow and Flow Reserve assessed by gated SPECT with cadmium-zinc-Telluride detectors using 99mTc-Tetrofosmin: head-to-Head comparison with 13 N-Ammonia PET. J Nucl Med. 2016;57(12):1887–92.

Article  PubMed  Google Scholar 

Desiderio MC, Lundbye JB, Baker WL, et al. Current status of Patient Radiation exposure of Cardiac Positron Emission Tomography and single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging. Circ Cardiovasc Imaging. 2018;11(12):e007565.

Article  PubMed  Google Scholar 

Mc Ardle BA, Dowsley TF, deKemp RA, et al. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60(18):1828–37.

Article  PubMed  Google Scholar 

Danad I, Raijmakers PG, Driessen RS, et al. Comparison of coronary CT angiography, SPECT, PET, and Hybrid Imaging for diagnosis of ischemic heart Disease determined by fractional Flow Reserve. JAMA Cardiol. 2017;2(10):1100–7.

Article  PubMed  PubMed Central  Google Scholar 

Schindler TH, Dilsizian V. Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):140–55.

Article  PubMed  Google Scholar 

Murthy VL, Bateman TM, Beanlands RS, et al. Clinical quantification of myocardial blood Flow using PET: joint position paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59(2):273–93.

Article  PubMed  Google Scholar 

Dayanikli F, Grambow D, Muzik O, et al. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90(2):808–17.

Article  PubMed  Google Scholar 

Parkash R, deKemp RA, Ruddy TD, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol. 2004;11(4):440–9.

Article  PubMed  Google Scholar 

Maddahi J, Packard RR. Cardiac PET perfusion tracers: current status and future directions. Semin Nucl Med. 2014;44(5):333–43.

Article  PubMed  PubMed Central  Google Scholar 

Berman DS, Maddahi J, Tamarappoo BK, et al. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2013;61(4):469–77.

Article  PubMed  Google Scholar 

Mou T, Zhang X. Research Progress on (18)F-Labeled agents for imaging of myocardial perfusion with Positron Emission Tomography. Molecules. 2017;22(4).

Madar I, Ravert HT, Du Y, et al. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med. 2006;47(8):1359–66.

PubMed  Google Scholar 

Packard RRS, Lazewatsky JL, Orlandi C, Maddahi J. Diagnostic performance of PET Versus SPECT myocardial perfusion imaging in patients with smaller left ventricles: a Substudy of the (18)F-Flurpiridaz phase III clinical trial. J Nucl Med. 2021;62(6):849–54.

Article  PubMed  PubMed Central  Google Scholar 

Maddahi J, Lazewatsky J, Udelson JE, et al. Phase-III clinical trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for evaluation of coronary artery disease. J Am Coll Cardiol. 2020;76(4):391–401.

Article  PubMed  Google Scholar 

Yalamanchili P, Wexler E, Hayes M, et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol. 2007;14(6):782–8.

Article  PubMed  Google Scholar 

Maddahi J, Agostini D, Bateman TM, et al. Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease. J Am Coll Cardiol. 2023;82(16):1598–610.

Article  PubMed  Google Scholar 

Mou T, Zhao Z, You L, et al. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET. J Label Comp Radiopharm. 2015;58(8):349–54.

Article  Google Scholar 

Mou T, Zhao Z, You L et al. Synthesis and evaluation of (18)F-labeled pyridaben analogues for myocardial perfusion imaging in mice, rats and Chinese mini-swine. Sci Rep. 2016;633450.

Ren C, Pan Q, Fu C et al. Phase I, first-in-human study of XTR004, a novel (18)F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest. J Nucl Cardiol. 2024;34101823.

Ohba T, Takano H, Kunimi T, et al. Direct comparison between pharmacological stress with adenosine triphosphate disodium and exercise stress myocardial perfusion imagings. J Cardiol. 2008;52(1):30–8.

Article  PubMed  Google Scholar 

García-Baizán A, Millor M, Bartolomé P, et al. Adenosine triphosphate (ATP) and adenosine cause similar vasodilator effect in patients undergoing stress perfusion cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2019;35(4):675–82.

Article  PubMed  Google Scholar 

Guehl NJ, Normandin MD, Wooten DW, et al. Single-scan rest/stress imaging: validation in a porcine model with (18)F-Flurpiridaz. Eur J Nucl Med Mol Imaging. 2017;44(9):1538–46.

Article  PubMed  Google Scholar 

Bengs S, Warnock GI, Portmann A, et al. Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: a feasibility study in mice. J Nucl Cardiol. 2023;30(1):62–73.

Article  PubMed  Google Scholar 

Hesse B, Tägil K, Cuocolo A, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2005;32(7):855–97.

Article  PubMed  Google Scholar 

Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77.

Article  PubMed  Google Scholar 

Hurwitz GA. Increased extra-cardiac background uptake on immediate and delayed post-stress images with 99Tcm sestamibi: determinants, independence, and significance of counts in lung, abdomen and myocardium. Nucl Med Commun. 2000;21(10):887–95.

Article  PubMed  Google Scholar 

Johansen A, Lomsky M, Gerke O, et al. When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy? EJNMMI Res. 2013;3(1):20.

Article  PubMed  PubMed Central  Google Scholar 

Hussain S, Sultan FAT. Role of carbonated water technique to enhance Tc-99m tetrofosmin myocardial perfusion imaging by reducing subdiaphragmatic artefacts. Ann Nucl Med. 2020;34(10):787–92.

Article  PubMed  Google Scholar 

Garcia EV, Cooke CD, Van Train KF, et al. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol. 1990;66(13):e23–31.